Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BA vs MRNA✓SelectedUSD · MRNABA vs MRNA performance historyLatest closeAs of-1.47%11/19
Stock and ETF performance explorer

BA vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-26.3%
MRNA return
+159.5%
Excess return
-185.8%
Maximum drawdown
-48.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.5%+1.3%-2.8%-1.5%
7D-6.4%-13.8%+7.4%-5.9%
30D-15.7%-17.7%+1.9%-15.2%
3M-27.8%+14.3%-42.1%-28.4%
6M-25.3%+336.0%-361.3%-34.0%
YTD-26.1%+575.9%-602.0%-39.1%
1Y-13.6%+724.4%-737.9%-30.8%
All-26.3%+159.5%-185.8%-32.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling